In order to more precisely identify the B cell phenotype in Wiskott-Aldrich Syndrome (WAS), we utilized three distinct murine in vivo models to define the cell intrinsic requirements for Wiskott-Aldrich Syndrome protein (WASp) in central vs. peripheral B cell development. While WASp is dispensable for early bone marrow B cell development, WASp deficiency results in a marked reduction in each of the major mature peripheral B cell subsets exerting the greatest impact on marginal zone (MZ) and B1a B
ABSTRACT
In order to more precisely identify the B cell phenotype in Wiskott-Aldrich Syndrome (WAS), we utilized three distinct murine in vivo models to define the cell intrinsic requirements for Wiskott-Aldrich Syndrome protein (WASp) in central vs. peripheral B cell development. While WASp is dispensable for early bone marrow B cell development, WASp deficiency results in a marked reduction in each of the major mature peripheral B cell subsets exerting the greatest impact on marginal zone (MZ) and B1a B cells. Using in vivo BrdU labeling and in vitro functional assays, we show that these deficits reflect altered peripheral homeostasis, partially due to an impairment in integrin function, rather than a developmental defect. Consistent with these observations we also show that: WASp expression levels increase with cell maturity peaking in those subsets exhibiting the greatest sensitivity to WASp deficiency; WASp + murine B cells exhibit a marked selective advantage beginning at the late transitional B cell stage; and, finally, that a similar in vivo selective advantage is manifest by mature WASp + human B cells.
Together, our data provide a better understanding of the clinical phenotype of WAS and suggest that gene therapy might be a useful approach to rescue altered B cell homeostasis in this disease.
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INTRODUCTION
Wiskott-Aldrich syndrome (WAS) is an X-linked immunodeficiency disorder characterized by recurrent infections, microthrombocytopenia and eczema. In addition, WAS is associated with an increased incidence of autoimmune disease and hematologic malignancies, especially B-cell lymphomas 1 . Affected patients are susceptible to bacterial, viral and fungal infections, secondary to defects in both cellular and humoral immunity. Lymphopenia is a common finding in WAS patients from infancy on, mainly due to reduced numbers of T cells whereas B cells are normal or moderately decreased 2, 3 . Antibody responses are adequate to some antigens and insufficient to others. In particular, WAS patients fail to respond to polysaccharide antigens and are highly susceptible to infections with S. pneumoniae 4 .
The affected gene, WASP, encodes a multidomain protein, WASp, which is exclusively expressed in hematopoietic cells and is the founding member of a family of proteins involved in the transduction of signals to the actin cytoskeleton 5 . The actin cytoskeleton plays a crucial role in cell adhesion and migration, antigen receptor surface assembly and turnover, and in formation of the T cell immunological synapse upon cell stimulation. Each of these pathways can be affected in WAS and contribute to the clinical phenotype. Several studies have demonstrated defective macrophage and DC migration and adhesion 4 , and more recent studies also suggest impaired trafficking of T and B cells as well as neutrophils [6] [7] [8] [9] . Both human and murine WASp-/-T cells exhibit defective actin polymerization, impaired TCR capping 10,11 12,13 , reduced ability to produce IL-2 and decreased proliferation in response to anti-CD3 stimulation in vitro 14 For personal use only. on October 28, 2017 . by guest www.bloodjournal.org From Studies investigating B cell function in both human and murine WAS have been more limited in scope and have led to varying results and interpretations. Study of EBV transformed B cell lines derived from WAS patients showed defective actin polymerization 15 . Ca ++ -flux upon BCR stimulation of human B cells has been reported to be normal 16 or reduced 17 . In WASp-/-mice, the proliferative response to BCR engagement was either slightly reduced 13 or normal 12, 13 . The latter study also showed normal capping of B cells in response to BCR stimulation. Westerberg et al demonstrated impaired polarization, spreading, homotypic aggregation and microvilli formation in response to CD40 stimulation; and defective migration to CXCL13 in WASp-/-primary murine B cells 8, 18 . In addition, both WAS patients and WASp-/-mice exhibit a marked reduction in the number of splenic marginal zone (MZ) B cells 8, 19 . These finding are consistent with the lack of antibody responses to pneumococcal polysaccharides in humans 2 and decreased antibody response to TI immunization with dextran in mice 8 .
In an effort to better understand the relative contributions of the B cell lineage to the immunodeficiency of WAS, we performed a detailed analysis of each of the major B cell developmental subsets in WASp-/-animals. We also utilized three independent in vivo models to precisely characterize the requirement for WASp in the central vs. BrdU incorporation. Mice were fed with BrdU continuously via the drinking water (1µg/ml BrdU (Sigma-Aldrich) and 10% sucrose) and sacrificed at indicated time points.
Cells from BM, spleen and peritoneal cavity were surface stained, then fixed and permeabilized, treated with DNase and stained with anti-BrdU FITC (BrdU Kit from BD Biosciences).
Immunological synapse analysis. Lipid bilayers with or without GPI-linked ICAM-1
were prepared by liposome spreading as previously described 20 . Briefly, Alexa 633streptavidin was incorporated into the bilayers and used to load anti-BCR at a density of 150 molecules/µm2 and alexa532-labelled GPI-linked ICAM-1 was either added or not at 80 molecules/µm2. B cells were settled on lipid bilayers and DIC images of several independent areas taken after 20 minutes. cSMAC frequency was determined by counting B cells aggregating anti-BCR and forming a cSMAC as a percentage of total B cells. IS frequency reflects B cells forming cSMACs and pSMACS as a percentage of all B cells forming cSMACs. The B cell contact area was quantified by IRM as described 21
Human peripheral blood. Peripheral blood was obtained from a WAS patient and healthy individuals following informed consent obtained according to the Declaration of 
RESULTS:

Specific defects in mature B cell subsets in WASp-/-mice.
WASp-/-mice were described almost a decade ago 12, 13 . While a recent report has demonstrated a reduction in splenic MZ B cell numbers 8 In addition and consistent with previous studies 8 
, MZP and MZ B cell
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From numbers were reduced 3-fold. In addition, cells with a CD21 hi CD1d hi phenotype, independent markers for the MZ lineage, were similarly reduced ( Fig. 1B ).
Next, we analyzed B1 cells in the peritoneal cavity which are crucial for TI immune responses. They can be further separated by CD5 into B1a (CD5 hi ) and B1b (CD5 low ) cells. Our analysis identified a relative increase in B1b cells (not shown) that reflected a relative and an absolute decrease in the number of B1a cells ( Fig 1D- 
fold reduction). We also determined the frequency of BM B1 cell precursors 23 and found no differences (Suppl. Fig. 1D ).
We conclude from this analysis that WASp deficiency does not affect early BM B 
WASp deficiency primarily impacts peripheral B cell homeostasis
The results described so far suggest that WASp-/-B cells manifest either a survival/homeostatic defect, or a specific developmental defect(s) leading, ultimately, to severely reduced numbers of mature MZ, B1a and recirculating naïve B cells.
Notch signaling plays a crucial role in MZ B cell development 24 . Since this subset is most severely affected in WASp-/-mice, we determined the expression of the Notch target genes, Hes1 and Deltex1 25 , in FM and MZ B cells from wt vs. WASp-/-mice.
Hes1, but not Deltex1, expression levels were consistently reduced in WASp-/-B cells suggestive of a partial defect in Notch2 signaling (Suppl. Fig. 4 ). However, when we determined Hes1 expression in FM and MZ B cells derived from chimeric BM transplant recipients as described above, no differences were observed (Suppl. Fig. 4A-B Experimental animals fed BrdU via the drinking water were sacrificed at day 3 or 7 and B cells analyzed for BrdU incorporation. As expected (based upon the lack of evidence for an early BM developmental defect), BrdU labeling was similar in early BM stages (Fraction A-E) and only slightly increased in T1 and T2 B cells (day 3; Fig. 5A and data not shown). In contrast, a significantly greater fraction of splenic FM, MZP and MZ B cells were BrdU + in WASp-/-mice ( Fig. 5A ). In addition, recirculating B cells exhibited faster labeling on days 3 and 7, respectively ( Fig. 5A and data not shown). B1a
and B1b populations exhibited significantly more BrdU + cells on day 3 and a trend for greater labeling at day 7 (Fig. 5B ). Comparing the BrdU labeling kinetics, it was evident that the turnover-rate of WASp-/-B cells was significantly higher beyond the T1 B cell stage. Notably, the absolute number of MZ B cells that incorporated BrdU was similar in both strains (Fig. 5C ) supporting the conclusion that the overall reduction in MZ B cell numbers in WASp-/-mice was unlikely to be due to a developmental defect. We also performed pulse-chase studies, by feeding BrdU for 7 days followed by analysis of splenic B cells on days 7 and 14 post-labeling. As expected, BrdU + FM and MZP/MZ B cells turned over significantly more rapidly in WASp-/-mice (Suppl. Fig 5A) . Consistent For personal use only. on October 28, 2017. by guest www.bloodjournal.org From supramolecular adhesion complex (pSMAC). Therefore, we compared the formation of the mature IS in wt and WASp-/-B cells following settling on planar lipid bilayers containing anti-BCR with or without ICAM-1. We observed that wt and WASp-/-B cells were able to aggregate activating antibody into a central SMAC (cSMAC) to a similar extent, both in the presence and absence of ICAM-1 (Fig 6A, B) 
WASp + human B cells exhibit a selective advantage in vivo.
To begin to determine whether our observations in this murine model were relevant to human B cell homeostasis, we initially analyzed WASp expression in peripheral B cell subsets derived from healthy individuals. As described previously, immature/transitional, naïve-mature, and IgM + memory B cells can be identified by relative staining for CD38, CD24, CD10 and IgM in human peripheral blood 30 (Fig. 7A ).
Using these markers in association with intracellular WASp staining, we analyzed expression of WASp in human peripheral B cell subsets. Consistent with work suggesting The peritoneal B1 cell compartment was previously described as unaltered in WASp-/-mice 12 . In contrast, whereas there was no difference in B1 progenitors in the BM, we observed a significant decrease in both percentage and absolute number of B1a cells; and a strong selective advantage for WASp expressing B1a and B1b cells. B1a B cells are crucial for protection against S. pneumoniae 34 . Thus, the increased susceptibility of WAS patients to encapsulated bacteria, which has also been described in WASp-/mice 35 , may be largely explained by the reduced number of both MZ and B1a B cells.
Consistent with these data, a recent study also demonstrated altered TI-type 2 immune responses in this strain 8 Overall, our phenotypic data in humans and mice are in accord with previous studies in WAS: the number of total B cells and MZ B cells are decreased in both human WAS patients and WASp-/-mice 4, 8, 13, 19 ; and similar to our observations in mice, a previous study also suggests that the relative percentage of immature peripheral B cells is increased in WAS patients 36 .
Our data clearly define the late transitional stage as the point at which WASp expression becomes crucial for B cell function. We also addressed the critical question as to whether this reflects a developmental vs. homeostatic defect. We excluded that impaired Notch signaling is the major reason for a diminished MZ B cell compartment.
Using in vivo BrdU labeling, we demonstrate significantly higher BrdU incorporation in splenic B cell subsets, recirculating BM B cells, as well as B1 B cells; findings consistent with a higher turn-over rate for each of these subpopulations. Notably, the absolute number of BrdU + MZ B cells was equal or even slightly higher in WASp-/-vs. wt mice. This latter finding essentially excludes a developmental defect because the number of newly generated MZ B cells is comparable. Moreover, cell cycle analysis revealed an increase in cycling cells (S-and G2/M-phase) in nearly all peripheral B cell subsets in WASp-/-mice. This feature was most pronounced in T2 B cells, the subset that is most highly responsive to homeostatic signals 25 . These coordinate findings suggest that an increase in newly generated B cells can partially compensate for homeostatic cell losses that occur in WASp-/-mice. Such compensation appears most efficient within the FM B cell pool as overall FM B cell numbers are not significantly reduced in WASp-/-mice.
Having excluded a developmental defect, we also tested whether key B cell intrinsic survival signals might be selectively impaired in WASp-/-mice. Previous reports have suggested an increased rate of spontaneous apoptosis in human B cells derived from peripheral blood of WAS patients 26, 37 . However, conclusions from these and other studies using B cells from WASp-/-mice are difficult to interpret because nearly all were performed using heterogeneous populations or cell lines. BCR and BAFF-R signals coordinately provide the crucial homeostatic and survival signals for late transitional and mature B cells 38 . Therefore, we tested both basal and/or receptormediated survival signals using highly purified, wt vs. WASp-/-B cell subsets. We were unable to identify any alterations in basal or receptor triggered signals including no differences in: relative receptor expression, cell survival, anti-apoptotic signaling, Akt activation, or p100 processing.
The absence of a survival defect in WASp-/-B cells suggests that alternative defects in homeostasis likely account for the observed losses within the mature B cell compartment. A previous study has shown a requirement for Pyk-2 driven, chemokine responses in MZ B cell development 39 and recent work has identified defects in chemokine-driven WASp-/-B cell migration 18 . However, because the initial pool of both MZ precursor and mature MZ B cells is intact in WASp-/-mice, altered migration alone For personal use only. on October 28, 2017. by guest www.bloodjournal.org From seems unlikely to explain the selective loss of these subsets. Instead, we predict that signals that promote retention of MZP/MZ B cells within the MZ niche are likely deficient in WASp-/-animals. MZ B cell localization requires up-regulation of LFA-1 and α4β1 integrins as well as signaling via Sphingosine-1-phosphate (S1P) receptors 29,40 41,42 . Transcript levels for S1P 3 , but not S1P 1 , were significantly decreased in MZ B cells from WASp-/-mice (Suppl. Fig. 4 ). However, because S1P 3 deficient mice exhibit normal MZ B cell numbers 41, 42 For personal use only. on October 28, 2017. by guest www.bloodjournal.org From
